Table 7 Relative binding energies (BE), inhibition constants, and interactions of GyrA WT and MTs with control antibiotics and best 3 lead compounds.

From: Exploring the potential role of GyrA inhibiting quinoline analog: an in silico study

Ligands

Target proteins (WT & MTs)

Binding energy (kcal/mol)

Inhibition constant (µM)

Conventional H-bond

Van der Waals interactions

CIP

gyrA

– 7.32

4.35

Lys42, Arg91, Asn165

His45, Thr88, Leu102, Leu166, Val168, Asn169, Ser171

 

gyrA_T83I

– 6.92

8.43

Lys42, Arg91, Asn165

His45, Thr88, Ser97, Leu102, Leu166, Val168, Ser171, Tyr267

 

gyrA_D87G

– 7.11

6.14

Lys42, Arg91, Asn165

Gly40, Leu41, His45, Thr88, Leu98, Leu102, Leu166,Val168, Asn169, Ser171, ser172, Tyr267

 

gyrA_D87N

– 7.26

4.73

Lys42, Arg91, Asn165

His45, Thr88, Leu102, Leu166,Val168, Asn169, Ser171, Ser172

 

gyrA_D87Y

– 7.09

6.34

Lys42, Arg91, Asn165

Gly40, Leu41, His45, Thr88, Leu102, Leu166,Val168, Asn169, Ser171, Ser172, Tyr267

 

gyrA_T83I_D87N

– 7.06

6.67

Lys42, Arg91, Asn165

Gly40, Leu41, His45, Thr88, Leu102, Leu166,Val168, Asn169, Ser171, Ser172

Average BE & Inh. const. of CIP

– 7.13

6.11

 

LEV

gyrA

– 6.66

13.13

Arg91, Asn169, Ser172

Gly40, Leu41, Thr88, Leu134, Asn165, Ser171

 

gyrA_T83I

– 6.59

14.76

Arg91, Asn169, Ser172

Gly40, Leu41, Thr88, Leu134, Asn165, Ser171

 

gyrA_D87G

– 6.65

13.32

Arg91, Asn169, Ser172

Gly40, Leu41, Thr88, Leu134, Asn165, Ser171

 

gyrA_D87N

– 6.42

19.8

Arg91, Asn169, Ser172

Gly40, Leu41, His45, Thr88, Leu134, Asn165, Ser171

 

gyrA_D87Y

– 6.67

12.96

Arg91, Asn169, Ser172

Gly40, Leu41, Thr88, Leu134, Asn165, Ser171

 

gyrA_T83I_D87N

– 6.47

18.08

Lys42, Thr88, Arg91

Gly40, Val44, His45, Asn87, Leu98, Leu102, Leu166, Asn169, Ser171, Ser172

Average BE & Inh. const. of LEV

– 6.58

15.34

 

M2

gyrA

– 8.13

1.1

Lys42, Gly170, Ser172

Pro35, Gly40, His45, Thr88, Arg91, Leu98, Leu102, Asn165, Leu166, Asn169

 

gyrA_T83I

– 8.1

1.16

Lys42, Gly170, Ser172

Pro35, Gly40, His45, Thr88, Arg91, Leu98, Leu102, Asn165, Leu166, Asn169

 

gyrA_D87G

– 8.15

1.06

Lys42, Gly170, Ser172

Pro35, Gly40, His45, Thr88, Arg91, Leu98, Leu102, Asn165, Leu166, Asn169

 

gyrA_D87N

– 8.14

1.09

Lys42, Gly170, Ser172

Pro35, Gly40, His45, Thr88, Arg91, Leu98, Leu102, Asn165, Leu166, Asn169

 

gyrA_D87Y

– 8.12

1.12

Lys42, Gly170, Ser172

Pro35, Gly40, His45, Thr88, Arg91, Leu98, Leu102, Asn165, Leu166, Asn169

 

gyrA_T83I_D87N

– 8.17

1.03

Lys42, Gly170, Ser172

Pro35, Gly40, His45, Thr88, Arg91, Leu98, Leu102, Asn165, Leu166, Asn169

Average BE & Inh. const. of M2

– 8.14

1.09

 

M9

gyrA

– 7.3

4.44

Lys42

Gly40, His45, Arg91, Met92, Asn165, Leu166, Asn169, Gly170, Ser171

 

gyrA_T83I

– 7.29

4.51

Lys42

Gly40, His45, Arg91, Leu102, Asn165, Leu166, Asn169, Gly170, Ser171

 

gyrA_D87G

– 7.38

3.92

Lys42

Pro35, Gly40, His45, Arg91, Met92, Leu102, Asn165, Leu166, Asn169, Gly170, Ser171

 

gyrA_D87N

– 7.31

4.41

Lys42

Gly40, His45, Arg91, Met92, Leu102, Asn165, Leu166, Asn169, Gly170, Ser171

 

gyrA_D87Y

– 7.34

4.15

Lys42

Pro35, Gly40, His45, Arg91, Met92, Leu102, Asn165, Asn169, Gly170, Ser171

 

gyrA_T83I_D87N

– 7.46

3.41

Lys42

Pro35, Gly40, His45, Arg91, Met92, Leu102, Asn165, Leu166, Asn169, Gly170, Ser171

Average BE & Inh. const. of M9

– 7.35

4.14

 

M11

gyrA

– 7.33

4.26

Lys42, Ser172

Gly40, Leu41, His45, Arg91, Met92, Asn169, Gly170, Ser171

 

gyrA_T83I

– 7.41

3.13

His 45

Pro35, Val44, Leu102, Asn165, Leu166, Asn169, Gly170, Ser171

 

gyrA_D87G

– 7.64

2.54

Lys42, His45

Pro35, Gly40, Val44, Thr88, Leu102, Asn165, Leu166, Asn169, Gly170, Ser171

 

gyrA_D87N

– 7.59

2.68

Lys42,His45

Pro35, Gly40, Val44, Thr88, Leu102, Asn165, Leu166, Asn169, Gly170, Ser171

 

gyrA_D87Y

– 7.22

5.03

Lys42, Ser172

Gly40, Leu41, His45, Arg91, Met92, Gly170, Ser171

 

gyrA_T83I_D87N

– 7.32

4.32

Lys42

Gly40, His45, Arg91, Leu98, Leu102, Asn169, Ser171

Average BE & Inh. const. of M11

– 7.42

3.6